Can insulin resistance and hyperinsulinemia lower SHBG and reduce measured total testosterone?

Sex hormone-binding globulin (SHBG) is a critical glycoprotein synthesized by the liver that serves as the primary transport vehicle for sex steroids. For men, particularly those in middle age, the relationship between metabolic health and SHBG levels is central to accurate hormonal assessment.

Hepatic mechanisms of SHBG suppression

There is strong evidence that insulin resistance and hyperinsulinemia directly suppress hepatic SHBG production.

• Molecular pathway: High circulating insulin levels activate sterol regulatory element-binding proteins (SREBPs). These proteins repress hepatocyte nuclear factor 4-alpha (HNF4α), which is the primary transcriptional activator required for the SHBG gene to produce the protein.
• Clinical findings: Epidemiological data show that men in the lowest quartiles of SHBG frequently exhibit higher HOMA-IR scores (a measure of insulin resistance) and a higher prevalence of metabolic syndrome. Research indicates that SHBG levels are often a more sensitive marker of liver fat and insulin sensitivity than many standard metabolic tests.

Impact on total testosterone measurements

Low SHBG concentrations inevitably lead to lower measured "total" testosterone levels, which can be clinically misleading.

• Binding capacity: Approximately 45–60% of circulating testosterone is tightly bound to SHBG. When SHBG levels drop due to metabolic dysfunction, the reservoir of bound testosterone decreases, lowering the total concentration measured in serum.
• HPG axis feedback: Mechanistically, low SHBG increases the amount of testosterone entering the hypothalamus and pituitary gland. This triggers an exaggerated negative feedback signal, suppressing the release of Luteinizing Hormone (LH) and further reducing testicular testosterone production.

Destabilization of androgen distribution and clearance

Low SHBG alters the kinetic stability and bioavailability of androgens, complicating the clinical picture.

• Increased bioavailability: While total testosterone decreases in low-SHBG states, the percentage of "free" (unbound) and bioavailable (albumin-bound) testosterone often increases relative to the total. This means a man with low total testosterone due to low SHBG may still have normal levels of tissue-active (free) testosterone.
• Accelerated clearance: SHBG acts as a buffer that prolongs the half-life of testosterone. Without adequate SHBG, testosterone is cleared more rapidly from the bloodstream by the liver, leading to a higher metabolic clearance rate (MCR) and less stable circulating levels.

Bottom line

The claim is strongly supported: hyperinsulinemia suppresses hepatic SHBG production via the HNF4α pathway, which lowers measured total testosterone and destabilizes androgen kinetics. In men with insulin resistance, total testosterone often underestimates androgenic status, making the measurement of free testosterone essential for an accurate diagnosis.